NCT00271024View on ClinicalTrials.gov

Efficacy of Naltrexone in Women's Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2010

Conditions
SmokingSmoking Cessation
Interventions
DRUG

Naltrexone (drug)

50 mg q.d. for 13 weeks

DRUG

Placebo (for Naltrexone)

Sugar pill manufactured to mimic Naltrexone tablet

Trial Locations (1)

60637

The University of Chicago, Department of Psychiatry, Chicago

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT00271024 - Efficacy of Naltrexone in Women's Smoking Cessation | Biotech Hunter | Biotech Hunter